Abstract
This presentation will give an update on renal tumours encompassing new entities [including tubulocystic renal cell carcinoma (RCC), acquired cystic disease associated RCC, clear cell tubulopapillary RCC, t(6;11) translocation carcinoma, and hereditary leiomyomatosis and RCC] and emerging entities [thyroid-like follicular RCC, succinate dehydrogenase B (SDHB) mutation associated RCC, and ALK-translocation associated RCC]. A summary of the entities accepted in these categories by consensus at the International Society of Urological Pathology meeting in Vancouver in March 2012 will be given. Discussion of important familial tumours involving the kidney will be included.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
